在首诊医院与非首诊医院接受后续泌尿系结石治疗的预测因素及费用比较
研究利用2016年佛罗里达州和纽约州HCUP州级数据库,识别因泌尿系结石急诊就诊后再次至首诊或非首诊医院就诊的成人患者,分析后续治疗地点预测因素及30天基于发作的费用。33,863例中9,593例(28.3%)在非首诊医院接受后续治疗,非首诊医院总费用更高,均值差783美元。
要点
- 非首诊医院接受后续治疗者占28.3%(9,593/33,863)。
- 首诊医院后续治疗与更少急性就诊次数(2.5 vs 2.7)和更短手术时间(29 vs 42天)相关。
- 非首诊医院总费用更高,均值差783美元(非首诊13,672美元 vs 首诊12,889美元)。
核心结论
- 初始泌尿系结石诊断后再次至不同医疗设施就诊与更多发作相关就诊、更长确定性手术时间和更高费用相关。
研究设计与样本
- 使用2016年HCUP州数据库(佛罗里达州和纽约州)全支付方数据,识别因泌尿系结石急诊就诊后再次至首诊或非首诊医院就诊的成人患者队列。
- 收集患者人口学、区域和手术信息,计算30天基于发作的费用,采用多变量逻辑回归和伽马广义线性回归分析预测因素和费用。
主要发现
- 33,863例发生泌尿系结石相关后续就诊的患者中,9,593例(28.3%)在非首诊医院接受治疗。
- 首诊医院后续治疗与更少急性就诊次数相关(2.5 vs 2.7;P<.001)。
- 首诊医院后续治疗与更短手术时间相关(29 vs 42天;P<.001)。
- 非首诊医院总费用更高,均值差783美元(非首诊:13,672美元,95%CI 13,292-14,053;首诊:12,889美元,95%CI 12,677-13,102;P<.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the effects of care fragmentation, or the engagement of different health care systems along the continuum of care, on patients with urinary stone disease. METHODS: All-payer data from the 2016 Healthcare Cost and Utilization Project (HCUP) State Databases from Florida (FL) and New York (NY) were used to identify a cohort of adult patients with an emergency department visit for a diagnosis of urolithiasis, who subsequently re-presented to an index or non-index hospital for renal colic and/or urological intervention. Patient demographics, regional data, and procedural information were collected and 30-day episode-based costs were calculated. Multivariable logistic and gamma generalized linear regression were utilized to identify predictors of receiving subsequent care at an index hospital and associated costs, respectively. RESULTS: Of the 33,863 patients who experienced a subsequent encounter related to nephrolithiasis, 9593 (28.3%) received care at a non-index hospital. Receiving subsequent care at the index hospital was associated with fewer acute care encounters prior to surgery (2.5 vs 2.7; P <.001) and less days to surgery (29 vs 42; P < .001). Total episode-based costs were higher in the non-index setting, with a mean difference of $783 (Non-index: $13,672, 95% CI $13,292-$14,053; Index: $12,889, 95% CI $12,677 - $13,102; P < .001). CONCLUSION: Re-presentation to a unique healthcare facility following an initial diagnosis of urolithiasis is associated with a greater number of episode-related health encounters, longer time to definitive surgery, and increased costs.
引用
- French WW, Scales CD, Viprakasit DP, et al. Predictors and Cost Comparison of Subsequent Urinary Stone Care at Index Versus Non-Index Hospitals. Urology. 2022. PMID: 35093397. doi:10.1016/j.urology.2022.01.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。